Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Pricing
SKY Learn

Sector: Pharmaceuticals & Biotechnology

Small Cap

Parmax Pharma Share Price

Q: What is the Market Capitalization of Parmax Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Parmax Pharma Ltd. is approximately ₹ 10.6 Cr.

Q: What are the PE and PB ratios for Parmax Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Parmax Pharma Ltd. is -2.1, and the Price-to-Book (PB) ratio is -1.7.

Q: What is the 52-Week High and Low for Parmax Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Parmax Pharma Ltd. shares was ₹ 55.02, and the lowest price was ₹ 22.6.

Q: Who are the major shareholders of Parmax Pharma Ltd.?

Significant shareholdings in Parmax Pharma Ltd. typically include entities such as: Public Promoter Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Parmax Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Parmax Pharma Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

Parmax Pharma Ltd.

₹31.43

2.99(10.51%)

Trade Now

1st Apr 2026 | 1:35 PM

NSE :

Open Free Demat Account

Parmax Pharma Performance

Price Movement

N/A

₹28.00

₹31.90

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹31.90

Low₹28.00

Open at₹31.90

Prev Close₹28.44

Volumes313

Avg Price₹30.00

Lower Circuit₹22.76

Upper Circuit₹34.12

Historical Performance

3M High₹42.00

3M Low₹22.60

1 Yr High₹55.02

1 Yr Low₹22.60

3 Yr High₹55.02

3 Yr Low₹22.60

5 Yr High₹81.90

5 Yr Low₹22.60

Parmax Pharma Fundamentals

Market Cap

Low in industry

10.60 Cr.

PE Ratio (TTM)

Negative PE TTM

-2.10

Dividend Yield

Net Profit TTM

147% decr over last year

-5.07

Net Profit Growth

147% decr over last year

-5.07

PEG Ratio

Below industry Median

ROE

100.0% incr over last year

Operating Revenue TTM

13.62

Operating Revenue Growth

51% decr over last year

Book Value

Negative Price to Book

-1.70

MFI

MFI oversold

28.63

RSI

RSI is mid-range

48.60

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

-1.70

Parmax Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	4.33	2.53	1.94	4.83	6.28
Operating Expense	4.52	4.12	2.19	5.39	6.18
Operating Profit	-0.20	-1.59	-0.25	-0.57	0.11
Depreciation	0.27	0.26	0.24	-0.18	0.41
Interest	0.28	0.24	0.28	0.24	0.11
Tax	0	0	0	-0.30	0
Net Profit	-0.73	-2.08	-0.76	-1.49	-0.39

Parmax Pharma Technicals

Parmax Pharma Ltd. EMA & SMA

₹31.43

6.21 (24.62%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹27

Day EMA10 ₹27.2

Day EMA12 ₹27.4

Day EMA20 ₹28.3

Day EMA26 ₹28.9

Day EMA50 ₹30.4

Day EMA100 ₹32

Day EMA200 ₹34.1

Parmax Pharma Support and Resistance

Resistance

First Resistance₹29.41

Second Resistance₹30.39

Third Resistance₹30.87

Support

First Support₹27.95

Second Support₹27.47

Third Support₹26.49

Technical Indicators

Day RSI48.60

Day MFI28.63

Day ADX36.95

Day Commodity Channel Index18.00

William-29.55

Day MACD-1.45

Day MACD Signal Line-1.50

Day ATR2.77

Day ROC125-14.08

Day ROC21-5.42

Parmax Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	30.8	30.8	30.8	30.8	30.8	30.8
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	69.2	69.2	69.2	69.2	69.2	69.2

Parmax Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	498	498	99.80%
Week	675	836	80.81%
1 Month	599	768	78.07%
6 Month	906	1.24 K	72.83%

Parmax Pharma SWOT Analysis

Strengths12

Weakness9

Opportunity0

Threats0

MACD Crossover Above Signal Line

Stocks whose current price is 20% higher than week low, and more than previous close

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Growth in Net Profit with increasing Profit Margin (QoQ)

Increasing Revenue every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

MACD crossed above signal line previous end of day

Top Gainers

Parmax Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Parmax Pharma Stock Comparison

Financials	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Aptus Pharma Ltd.	Amanta Healthcare Ltd.
Price (₹)	₹217	₹36.87	₹5.54	₹99.90	₹345.05	₹105.90
% Change	4.35%	1.99%	4.92%	7.48%	-1.17%	6.10%
Revenue TTM (₹ Cr)	-	₹0.54	₹83.60	-	-	₹282.74
Net Profit TTM (₹ Cr)	-	₹-0.24	₹-34.95	-	-	₹15.30
PE TTM	60.10	-91.90	-1.30	12.30	77.30	25.30
1 Year Return		703.33	428	-27.38		-20.79
ROCE	-	-	-5.63	-	-	-

Similar Stocks

AHCL

Anlon Healthcare Ltd.

₹ 112.54

+1.04%

MEDISTEP

Medistep Healthcare Ltd.

₹ 17.30

+4.85%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 58.01

-5.95%

APL

Asston Pharmaceuticals Ltd.

₹ 78.80

+7.95%

INFLUX

Influx Healthtech Ltd.

₹ 213.20

+5.54%

MEDIORG

Medicamen Organics Ltd.

₹ 22.15

+4.98%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 498.50

+0.98%

ASTONEALAB

Astonea Labs Ltd.

₹ 159.60

+4.25%

AMWILL

Amwill Health Care Ltd.

₹ 30.39

+4.97%

SENORES

Senores Pharmaceuticals Ltd.

₹ 774.50

+1.96%

INNOVACAP

Innova Captab Ltd.

₹ 702.00

+1.76%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 57.40

+11.20%

SHELTER

Shelter Pharma Ltd.

₹ 29.78

+11.00%

TLL

Trident Lifeline Ltd.

₹ 262.75

-2.09%

DPL

Dipna Pharmachem Ltd.

₹ 9.25

+15.34%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.62

+6.64%

FABINO

Fabino Enterprises Ltd.

₹ 15.94

+4.94%

SUPRIYA

Supriya Lifescience Ltd.

₹ 600.00

+6.78%

SIGACHI

Sigachi Industries Ltd.

₹ 19.22

+13.59%

WINDLAS

Windlas Biotech Ltd.

₹ 771.00

+4.65%

VINEETLAB

Vineet Laboratories Ltd.

₹ 29.50

+1.51%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 32.00

+4.92%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 460.50

+8.21%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.44

+10.00%

FAQ's on PARMAX

What is the Market Capitalization of Parmax Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Parmax Pharma Ltd. is approximately ₹ 10.6 Cr.

What are the PE and PB ratios for Parmax Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Parmax Pharma Ltd. is -2.1, and the Price-to-Book (PB) ratio is -1.7.

What is the 52-Week High and Low for Parmax Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Parmax Pharma Ltd. shares was ₹ 55.02, and the lowest price was ₹ 22.6.

Who are the major shareholders of Parmax Pharma Ltd.?

Significant shareholdings in Parmax Pharma Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Parmax Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Parmax Pharma Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy